23andMe wants to become a drug company, has 13 drugs in its pipeline: 5 notes

Becker's Healthcare February 15, 2019
Alia Paavola

23andMe, known for its at-home DNA testing kits, is working on creating its own drugs for a range of ailments, including skin treatments to heart disease, according to Business Insider.

Five things to know:

1. The genetic testing startup, which began its venture into creating new drugs in 2015, now has 13 drug candidates in its pipeline. Two of those medications are in the animal testing phase.

2. A former Genentech executive Richard Scheller heads up the program at 23andMe and a team of 70 scientists are focused on testing the compounds.

3. 23andMe cofounder and CEO Anne Wojcicki said it would be a “source of pride”...

Today's Sponsors

Today's Sponsor